Clinical Trials Browser

Completed × Esophageal Neoplasms × durvalumab × Clear all

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT03212469 2025-05-08

ABIMMUNE

Phase 1/2 Completed

54 enrolled

GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Neoplasms, Lung Neoplasms

NCT02735239 2024-03-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Phase 1/2 Completed

73 enrolled 18 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02639065 2023-09-25

A Study of Durvalumab (MEDI4736) in Esophageal Cancer

Phase 2 Completed

39 enrolled 12 charts

Gastrointestinal

Esophageal Neoplasms

Clinical Trials

ARION

ABIMMUNE

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

A Study of Durvalumab (MEDI4736) in Esophageal Cancer